| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 35 |
| 1 | ISOTRETINOIN | 13 |
| 2 | BEVACIZUMAB | 12 |
| 3 | AZATHIOPRINE | 7 |
| 4 | INFLIXIMAB | 6 |
| 5 | MYCOPHENOLATE MOFETIL | 5 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 5 |
| 7 | TACROLIMUS | 5 |
| 8 | CAPECITABINE | 4 |
| 9 | CERTOLIZUMAB PEGOL | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE | 1 | 0.0011 |
| 1 | IRON DEXTRAN | 1 | 0.0007 |
| 2 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 1 | 0.0004 |
| 3 | COLESTIPOL HYDROCHLORIDE | 1 | 0.0004 |
| 4 | LEVOLEUCOVORIN INJECTION | 1 | 0.0003 |
| 5 | LEVOLEUCOVORIN | 1 | 0.0003 |
| 6 | ISOTRETINOIN | 13 | 0.0003 |
| 7 | PANITUMUMAB | 4 | 0.0002 |
| 8 | MERCAPTOPURINE | 3 | 0.0002 |
| 9 | NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 1 | Epidermal Growth Factor Receptor Antagonist [EPC] | 4 | 0.0001 |
| 2 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 3 | Purine Antimetabolite [EPC] | 7 | 0.0001 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 13 | 0.0001 |
| 5 | Anticholinergic [EPC] | 1 | 0.0001 |
| 6 | Nitrofuran Antibacterial [EPC] | 1 | 0.0001 |
| 7 | Retinoid [EPC] | 13 | 0.0001 |
| 8 | Aminosalicylate [EPC] | 3 | 0.0000 |
| 9 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |